Rhythm Pharmaceuticals Inc (RYTM)
Cost of Revenue
$26.39M
TTM · Period ending: · USD
RYTM Cost of Revenue
Latest reported$26.39Mperiod ending
Latest reported$26.39Mperiod ending
RYTM TTM Cost of Revenue ($0.00 → $26.39M)
TTM cost of revenue
High-resolution chart · PNG
RYTM cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 26,389,000 | |
| 23,001,000 | |
| 19,492,000 | |
| 18,477,000 | |
| 16,806,000 | |
| 14,210,000 | |
| 13,369,000 | |
| 12,815,000 | |
| 11,399,000 | |
| 10,688,000 | |
| 9,302,000 | |
| 7,097,000 | |
| 5,182,000 | |
| 3,324,000 | |
| 2,133,000 | |
| 1,341,000 | |
| 1,066,000 | |
| 825,000 | |
| 599,000 | |
| 363,000 | |
| 141,000 | |
| 4,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |